title: Vemurafenib-associated gingival hyperplasia in patient with metastatic melanoma.
authors.affiliation: Department of Dermatology, Mayo Clinic, Scottsdale, Arizona.
authors.forename: Aaron R
authors.initials: AR
authors.lastname: Mangold
authors.affiliation: Department of Internal Medicine, Division of Oncology, Mayo Clinic, Scottsdale, Arizona.
authors.forename: Alan
authors.initials: A
authors.lastname: Bryce
authors.affiliation: Department of Dermatology, Mayo Clinic, Scottsdale, Arizona. Electronic address: sekulic.aleksandar@mayo.edu.
authors.forename: Aleksandar
authors.initials: A
authors.lastname: Sekulic
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D005885:Gingival Hyperplasia / Q000139:chemically induced*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib